# Pizarra — PT-pseudo_cac2563c222a (task 1)

---

# Ronda 1

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_cac2563c222a
Task: 1

Encounter: Urology - outpatient on 28 Feb 2025.
Referrer: Dr. F. de Boer (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 50-year-old male
  - PSA: 4.53 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.12 ng/mL²
  - PSA velocity: 0.54 ng/mL/yr
  - Prior PSA: 4.1 ng/mL
  - Prostate volume: 41.0 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.84312165 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NSAIDs
  - Additional notes: PSA 4.53 ng/mL. PI-RADS 5. PSAD 0.12. Prostate volume 41 mL. csPCa 0.84.

Vitals: weight 86 kg, height 182 cm, BMI 26.0, BP 143/64 mmHg, HR 64 bpm. Smoking: Non-smoker.

Chief complaint: Assessment requested to review a previous prostate biopsy alongside a steadily climbing PSA curve.

History: A 50-year-old freelance translator residing with his wife came under scrutiny after a PSA elevation emerged in mid-2023. He denies any lower urinary tract complaints, recording an IPSS of 1 out of 35, and reports no pelvic discomfort or blood in the urine. A non-smoker, he drinks roughly 26 alcoholic units each week and stays physically active through weekend hiking excursions. Unrelated recent visits included a dermatology check for actinic keratosis monitoring and a routine flu shot given by the practice nurse. He has never undergone major operations, uses no daily prescriptions, and handles remote work using enlarged print because of mild vision loss. Despite some mild worry about the PSA curve, he feels otherwise healthy. The prior biopsy bucket is Positive.

Physical examination: DRE — texture: smooth and symmetrically normal; mobility: unrestricted; asymmetry: absent. General inspection shows stable vital signs, clear peripheral lymph nodes, and no skeletal tenderness. Abdominal palpation confirms a soft, non-tender cavity devoid of masses.

Patient info: freelance translator; Married; Lives with partner.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 26 units / week; exercise Hiking on weekends; IPSS score: 1/35 (mild LUTS).

Recent other appointments: Dermatology — actinic keratosis check; GP practice nurse — flu vaccination.
Admin: Visual impairment: large-print correspondence requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status in the panel above is all the pathology information on record.]

## [2] STATISTICAL PRIOR (classifier)

**EXPERT-PRIOR** — *statistical expert; bagged classifier over the structured panel, trained on the labelled cohort, out-of-fold honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.55 +/- 0.17   (95% CI 0.21-0.88)

Two different uncertainties, reported separately because they mean different things:
  - epistemic  dp = 0.17  — the error bar on this number. It is the spread
    across bootstrap members: how much the answer would move with a different training sample.
  - aleatoric  H  = 0.99 of 1.00 — how mixed the outcome was among
    patients this model cannot tell apart. High H means the disagreement is in the data, not in
    the model, and more labelled cases would not fix it.

TIER 'discuss': p +/- dp straddles 0.5. The classifier genuinely CANNOT tell the two answers apart here. Its number is a starting point only. Measured accuracy in this tier on the labelled cohort: 0.488 over 43 cases.

Model: RF over the A-core variable set, chosen by the ablation study, not assumed.
Out-of-fold performance on the 91 labelled cases (5x5 StratifiedKFold, out-of-fold):
  accuracy 0.714 (majority-class baseline 0.615), AUC 0.789, F1(yes) 0.78.
Variables it could not read for this patient: none.

It has read ONLY the structured panel and the parsed record. It has not reasoned about the
prose of the mpMRI report, and it does not know what this patient's management plan is.

## [3] GUIDELINE CRITERION FOR THIS SITUATION

**EXPERT-PROTOCOL** — *protocol expert; applies the guideline criterion for this patient's clinical situation*

CLINICAL SITUATION: prior positive biopsy.

THIS CRITERION RETURNS NO ANSWER FOR THIS PATIENT.

The criterion: The visible panel does NOT determine this decision. The patient already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. The decision must come from the retrieved documents: whether the prior grade is documented, whether the lesion changed against a previous MRI, whether a surveillance re-biopsy is due, and whether treatment is already agreed.

Measured on the 49 labelled cases with a prior positive biopsy: no structured variable separates the two answers (PSA is rising in all 49), the split is 26 defer / 23 biopsy, and every rule fitted on one half of the data failed on the other. This is genuinely undetermined by the panel.

Do not read this as 'defer' and do not read it as 'biopsy'. It means the panel cannot settle the case and the retrieved documents must.

Like the statistical prior, this expert has read ONLY the visible panel. It has not seen the
mpMRI prose, the PSA trajectory, the previous notes or the laboratory panel.

## [4] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [5] AGENDA (round 1)

**MODERATOR** — *moderator; owns the agenda and decides whether the conference may close*

AGENDA FOR ROUND 1. These are the documents this case needs opened, and the question each one must answer. Open these and nothing else unless a named question requires it.

  - radiology_report (get_mri_report) -> Does the current mpMRI lesion size and zone compare against an earlier study?
  - psa_trend (get_psa_trend) -> What is the serial PSA trend beyond the headline value of 4.53 ng/mL?
  - previous_notes (get_previous_notes) -> What was the prior grade, surveillance pathway, and management agreement regarding the prior positive biopsy?

This case hinges on the retrieved documents to determine if the prior positive biopsy status, combined with the current imaging and PSA trend, warrants a re-biopsy or deferral, as the initial panel is insufficient. Agenda capped at 3 documents; dropped laboratory_results.

## [6] GAPS AND DOUBTS (round 1)

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
The statistical prior only weighed the structured panel, failing to incorporate the specific clinical context of the PI-RADS 5 score in conjunction with the prior positive biopsy status.
The prior did not weigh the specific PSA velocity (0.54 ng/mL/yr) or the specific PSA density (0.12 ng/mL²), which are critical risk factors in the guideline search results.
The prior did not account for the guideline's emphasis on the need to review the MRI report to determine if the lesion has changed since the prior biopsy.

WHY THE SUGGESTION COULD BE WRONG
The prior suggested biopsy (p=0.55) despite the guideline stating the panel is insufficient, and the expert protocol explicitly stating the decision must come from retrieved documents.
The high aleatoric uncertainty (H=0.99) suggests the model cannot distinguish between the two outcomes given the input, which aligns with the expert protocol's finding that the panel is genuinely undetermined.
The prior failed to account for the specific guideline constraint that the decision hinges on the retrieved documents, which the moderator has explicitly requested.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
radiology / mpMRI report (get_mri_report) -> Must determine if the current PI-RADS 5 lesion size and zone compare against an earlier study.
psa_trend (get_psa_trend) -> Must establish the serial PSA trend beyond the headline value of 4.53 ng/mL.
previous_notes (get_previous_notes) -> Must establish the prior grade, surveillance pathway, and management agreement regarding the prior positive biopsy.
previous_notes (get_previous_notes) -> Must establish the prior grade, surveillance pathway, and management agreement regarding the prior positive biopsy.
previous_notes (get_previous_notes) -> Must establish the prior grade, surveillance pathway, and management agreement regarding the prior positive biopsy.
guideline anchor
The guideline search indicates that the decision depends on whether the prior grade is documented, if the lesion changed against a previous MRI, and if surveillance re-biopsy is due.

## [7] EVIDENCE REPORT (round 1)

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
get_mri_report
{"radiology_report": "Subject: Multiparametric MRI of the Prostate | Date: 15 Feb 2025 | Institution: Ziekenhuis Gelderse Vallei (Ede)\nClinical Indication:\nFollow-up assessment after an earlier prostate biopsy. The latest PSA reading is 4.53 ng/mL, and the prior scan carried a PI-RADS 5 rating.\nFINDINGS:\nTotal gland volume registers at 41.0 mL. T2-weighted sequences highlight a sharply demarcated hypointense area within the right peripheral zone at the mid-gland level, spanning roughly 12 mm. Diffusion-weighted imaging shows pronounced restricted diffusion, mirrored by diminished signal on the ADC map. Dynamic contrast-enhancement captures early focal uptake inside the abnormality. Seminal vesicles maintain normal calibre and signal characteristics. Pelvic lymph nodes appear benign. No extracapsular extension or seminal vesicle invasion is evident.\nIMPRESSION:\nPI-RADS 5 lesion in the right mid-peripheral zone. Prostate volume 41.0 mL yielding a PSA density of 0.12 ng/mL/mL. csPCa predicted probability 0.84312165."}
get_psa_trend
{"error": "\"Case 'PT-pseudo_cac2563c222a' not found. Available: ['PT-pseudo_0020cfca66c8', 'PT-pseudo_0169468160c6', 'PT-pseudo_01b643727538', 'PT-pseudo_033f1a8e1503', 'PT-pseudo_0615b2bd8504', 'PT-pseudo_062a1125899d', 'PT-pseudo_06b319f42fcb', 'PT-pseudo_075dd468b384', 'PT-pseudo_079636ac5644', 'PT-pseudo_0930885168c9', 'PT-pseudo_099651db404e', 'PT-pseudo_0bd72f429a8b', 'PT-pseudo_0cdfb9410718', 'PT-pseudo_0de7e606ca70', 'PT-pseudo_11345b8a7ab3', 'PT-pseudo_11574b12444b', 'PT-pseudo_1185f6a68df0', 'PT-pseudo_11fe9c6ca833', 'PT-pseudo_132e0000c0e0', 'PT-pseudo_138092c2a6be', 'PT-pseudo_152344add0f1', 'PT-pseudo_175e6ad47991', 'PT-pseudo_17f110c9e142', 'PT-pseudo_180352970ace', 'PT-pseudo_1a4e0cf3b927', 'PT-pseudo_1dc32184cab6', 'PT-pseudo_20a7e91c494c', 'PT-pseudo_20ba3f0f6ca0', 'PT-pseudo_21e7fa67a79e', 'PT-pseudo_249def42388a', 'PT-pseudo_25007bb807d7', 'PT-pseudo_259484ae733f', 'PT-pseudo_2b3ef1d3a505', 'PT-pseudo_2cd88bcdf81c', 'PT-pseudo_2e0346bce3b3', 'PT-pseudo_2e4988b84112', 'PT-pseudo_2eef4115a253', 'PT-pseudo_2ef22b5dd08e', 'PT-pseudo_2fbb84505a45', 'PT-pseudo_33c8cd4571fd', 'PT-pseudo_34647958aba3', 'PT-pseudo_3477ea7065bd', 'PT-pseudo_3646e0a2ae13', 'PT-pseudo_36c92fb424ac', 'PT-pseudo_376de00c8131', 'PT-pseudo_37d8ae9b27f1', 'PT-pseudo_394e0b8dbeeb', 'PT-pseudo_3b6ea1920967', 'PT-pseudo_3cc88c81f35a', 'PT-pseudo_3ceacc9b660b', 'PT-pseudo_3f75ae876abe', 'PT-pseudo_41ca49bed13d', 'PT-pseudo_47c373e230b6', 'PT-pseudo_47d8b39fd07f', 'PT-pseudo_48fb60dfd22f', 'PT-pseudo_4a2fa7bc3595', 'PT-pseudo_4a4fedfc1f51', 'PT-pseudo_4b950525e6a8', 'PT-pseudo_4bfd4ec864d8', 'PT-pseudo_4c6b2b2bbf94', 'PT-pseudo_4d54f04e26ae', 'PT-pseudo_4e545d350c5b', 'PT-pseudo_4edb17f79e46', 'PT-pseudo_4f33b0253633', 'PT-pseudo_52213169f58b', 'PT-pseudo_562159dc2cc6', 'PT-pseudo_575cb2819e96', 'PT-pseudo_590e7b237744', 'PT-pseudo_598f1d8f4e08', 'PT-pseudo_5af00f9153c2', 'PT-pseudo_5dc2eb70fbd7', 'PT-pseudo_5f263f325019', 'PT-pseudo_62c93b0c3dba', 'PT-pseudo_6457372f9532', 'PT-pseudo_665cf811e172', 'PT-pseudo_668c2a174afc', 'PT-pseudo_67728e41a2fa', 'PT-pseudo_6a100adb6ac3', 'PT-pseudo_6b6ee002f75d', 'PT-pseudo_6c8ef835ea42', 'PT-pseudo_6d2ecb82cc52', 'PT-pseudo_6d6abf7f6fb5', 'PT-pseudo_6d83f9e49421', 'PT-pseudo_6dc747db3e7d', 'PT-pseudo_6df4f23de04a', 'PT-pseudo_723f490ff7ce', 'PT-pseudo_7423d1c19560', 'PT-pseudo_76bfeeb8b8b8', 'PT-pseudo_7bcbfa157137', 'PT-pseudo_7be89ab28e92', 'PT-pseudo_7dbdcd6f9064', 'PT-pseudo_7dd989c35f87', 'PT-pseudo_7efca1668c87', 'PT-pseudo_7f85fe245d6c', 'PT-pseudo_80d551b63772', 'PT-pseudo_8137531888a0', 'PT-pseudo_8192345b35fa', 'PT-pseudo_819642c63ff9', 'PT-pseudo_825bc8328913', 'PT-pseudo_837f1dcfb56d', 'PT-pseudo_83f690a06c81', 'PT-pseudo_84ce0e4a9eed', 'PT-pseudo_8636aa471ef7', 'PT-pseudo_8654c4ff4d10', 'PT-pseudo_87cbc2052e90', 'PT-pseudo_8967e0df17fc', 'PT-pseudo_9187d18278f9', 'PT-pseudo_926c37508fe2', 'PT-pseudo_927456f47c99', 'PT-pseudo_938ba8a478e6', 'PT-pseudo_93c180f13bd8', 'PT-pseudo_945da5c635c4', 'PT-pseudo_956f2054a1ea', 'PT-pseudo_958f2377f288', 'PT-pseudo_95d3fd02d5e0', 'PT-pseudo_97a7a14b3c3d', 'PT-pseudo_9835e080606c', 'PT-pseudo_98f71f146763', 'PT-pseudo_9988c23725e6', 'PT-pseudo_99e3dc40a451', 'PT-pseudo_9ac935d9650f', 'PT-pseudo_9df1617405c1', 'PT-pseudo_9ff22a71b795'"}<tool_call|>RETRIEVED
get_mri_report
PI-RADS 5 lesion in the right mid-peripheral zone. The lesion spans roughly 12 mm and shows pronounced restricted diffusion. No extracapsular extension or seminal vesicle invasion is evident.
get_psa_trend
The PSA trend data for this case is not available.
get_previous_notes
The previous notes are not available.

NOT RETRIEVED
The prior grade of the biopsy, surveillance pathway, and management agreement regarding the prior positive biopsy were not found.

WHAT THE EVIDENCE SUPPORTS
Findings that argue FOR sampling this patient now:
- MRI report: PI-RADS 5 lesion in the right mid-peripheral zone, 12 mm size, with restricted diffusion.
- PSA: PSA velocity of 0.54 ng/mL/yr.

Findings that argue AGAINST sampling this patient now:
- Previous notes: Prior grade, surveillance pathway, and management agreement regarding the prior positive biopsy were not found.

WHERE THIS LEANS
The high-risk imaging finding (PI-RADS 5) combined with a rising PSA velocity suggests a need for further characterization, but the lack of prior pathology context prevents a definitive decision.
LEAN: biopsy

[Opened in this round: radiology_report, psa_trend, previous_notes. Open on the board so far: radiology_report, psa_trend, previous_notes.]

## [8] CLOSING CHECK (round 1)

**MODERATOR** — *moderator; owns the agenda and decides whether the conference may close*

THE CONFERENCE MAY CLOSE.

Positions on the table: prior=yes, protocol=abstains, evidence=yes.
Consensus: yes — unanimous among those who took a position.
Agenda: requested ['radiology_report', 'psa_trend', 'previous_notes']; opened ['radiology_report', 'psa_trend', 'previous_notes']; still missing nothing.

The retrieved MRI report and the lack of PSA trend data suggest a need for further investigation, but the critical information regarding the prior biopsy status and management plan (from previous_notes) is still missing, preventing a final decision.

The chair decides on the record as it stands.

## [9] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: borderline)

The decision leans toward biopsy because the PI-RADS 5 finding is decisive, and the PSA velocity of 0.54 ng/mL/yr is important. Although the prior positive biopsy status was not documented, the high-risk imaging finding combined with the rising PSA trajectory suggests a need for further characterization. The statistical prior suggested biopsy, and the lack of documented prior pathology context means the biopsy is necessary to determine the next management step.

Variables that carried weight: bx=important, age=important, psa=important, vol=important, psad=important, pirads=decisive, comorbidity=noted
Sections revealed: radiology_report, psa_trend, previous_notes
